Neumora Therapeutics (NMRA) News
NASDAQ: NMRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.3339-0.0131 (-3.78%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NMRA news summary
We found 2 recent headlines mentioning Neumora Therapeutics (NMRA): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, NMRA is down 3.78% at $0.3339. The most recent story, "Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Neumora Therapeutics headlines
- Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business UpdateNeumora Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2026, and provided a business update. The Company reported a net loss of $34.4 million for the third…Nasdaq
- Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business UpdateIND application for NMRA-215 (NLRP3 inhibitor) submitted to the U.S. Food and Drug AdministrationGlobeNewswire